Anktiva®联合BCG在不对BCG应答的高等级乳头状非肌肉侵袭性膀胱癌患者中,三年生存率达96%,中位生存期尚未达到

美股速递
Dec 16, 2025

Anktiva®联合BCG在不对BCG应答的高等级乳头状非肌肉侵袭性膀胱癌患者中,三年生存率达96%,中位生存期尚未达到。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10